Literature DB >> 23153789

Usefulness of stereotactic biopsy and neuroimaging in management of HIV-1 Clade C associated focal brain lesions with special focus on cerebral toxoplasmosis.

C Shyam babu1, P Satishchandra, A Mahadevan, V Pillai Shibu, S Ravishankar, N Sidappa, R Udaykumar, V Ravi, S K Shankar.   

Abstract

BACKGROUND: Focal brain lesions (FBL) in HIV/AIDS frequently pose a diagnostic dilemma as the etiology varies from infective (tuberculoma, toxoplasmosis and tuberculous abscesses) to neoplastic lesions like lymphoma. For determining etiology, advanced neuroimaging techniques, serological and molecular biological tests have been evolved with varying sensitivities/specificities. Stereotactic biopsy (STB) of the lesions is reserved for lesions unresponsive to appropriate therapy. OBJECTIVE AND METHODS: In this study, the diagnostic yield of neuroimaging [cranial CT (n=25), MRI (n=24), and Th201/99Tc SPECT scan (n=18)] is compared with histopathological diagnosis obtained by STB (n=21) or autopsy (n=4) in 25 HIV-1 subtype C seropositive individuals with FBL identified by neuroimaging with special reference to cerebral toxoplasmosis in an eighteen month study period (2006-2007). RESULTS AND
CONCLUSION: Cerebral toxoplasmosis was the most frequent cause of FBL (21/25, 84%), followed by one case each of tuberculoma, progressive multifocal leukoencephalopathy (PML), primary central nervous system lymphoma (PCNSL) and measles inclusion body encephalitis (MIBE), the last two diagnosed at autopsy. Of the 21 cases of cerebral toxoplasmosis, definitive diagnosis with histopathological confirmation was available in 14/21 (66.6%), with indirect evidence suggesting probable toxoplasmosis in seven, all of whom responded to antitoxoplasma therapy. CT and MRI had comparable specificities (75%), while MRI had marginally higher sensitivity (85% versus 80.9%) in detecting multiple lesions. The positive predictive value of both CT and MRI was identical (94.4%), suggesting that CT maybe a cost effective screening tool in resource restricted settings, for evaluating FBL. Sensitivity of 99Tc SPECT scan for diagnosing inflammatory lesions was 75% but failed to differentiate PCNSL from toxoplasmosis. This study is the first of its kind from India analyzing FBL with specific focus on cerebral toxoplasmosis in the setting of HIV-1 subtype C.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23153789      PMCID: PMC4483268          DOI: 10.1016/j.clineuro.2012.10.012

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  25 in total

Review 1.  The neurology of HIV infection.

Authors:  H Manji; R Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

Review 2.  Infectious lesions mimicking central nervous system neoplasms.

Authors:  Vani Santosh; Anita Mahadevan; Yasha T Chickabasaviah; Rose Dawn Bharath; Shankar S Krishna
Journal:  Semin Diagn Pathol       Date:  2010-05       Impact factor: 3.464

3.  Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS.

Authors:  R F Miller; M A Hall-Craggs; D C Costa; N S Brink; F Scaravilli; S B Lucas; I D Wilkinson; P J Ell; B E Kendall; M J Harrison
Journal:  Sex Transm Infect       Date:  1998-08       Impact factor: 3.519

4.  The role of stereotactic biopsy in the management of HIV-related focal brain lesions.

Authors:  E T Chappell; B L Guthrie; J Orenstein
Journal:  Neurosurgery       Date:  1992-06       Impact factor: 4.654

5.  [Cerebral lesions in AIDS: what can be expected from scintigraphy? Cerebral tomographic scintigraphy using thallium-201: a contribution to the differential diagnosis of lymphomas and infectious lesions].

Authors:  I Berry; J F Gaillard; Z Guo; Y S Cordoliani; P Massip; C Manelfe; B Danet
Journal:  J Neuroradiol       Date:  1995-09       Impact factor: 3.447

Review 6.  Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases.

Authors:  J R Berger; B Kaszovitz; M J Post; G Dickinson
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

7.  Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India.

Authors:  Nagadenahalli B Siddappa; Prashanta K Dash; Anita Mahadevan; Narayana Jayasuryan; Fen Hu; Bethany Dice; Randy Keefe; Kadappa S Satish; Bhuthiah Satish; Kuttan Sreekanthan; Ramdas Chatterjee; Kandala Venu; Parthasarathy Satishchandra; Vasanthapuram Ravi; Susarla K Shankar; Raj Shankarappa; Udaykumar Ranga
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

Review 8.  Neurologic manifestations of HIV infection.

Authors:  D M Simpson; M Tagliati
Journal:  Ann Intern Med       Date:  1994-11-15       Impact factor: 25.391

9.  Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients.

Authors:  B A Navia; C K Petito; J W Gold; E S Cho; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

Review 10.  NIH conference. Recent advances in the management of AIDS-related opportunistic infections.

Authors:  H C Lane; B E Laughon; J Falloon; J A Kovacs; R T Davey; M A Polis; H Masur
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

View more
  6 in total

1.  Longitudinal cerebral metabolic changes in pig-tailed macaques infected with the neurovirulent virus SIVsmmFGb.

Authors:  Chun-Xia Li; Xiaodong Zhang; Amelia Komery; Yingxia Li; Hui Mao; James G Herndon; Francis J Novembre
Journal:  J Neurovirol       Date:  2014-11-07       Impact factor: 2.643

2.  CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  M Schmidt-Hieber; G Silling; E Schalk; W Heinz; J Panse; O Penack; M Christopeit; D Buchheidt; U Meyding-Lamadé; S Hähnel; H H Wolf; M Ruhnke; S Schwartz; G Maschmeyer
Journal:  Ann Oncol       Date:  2016-04-06       Impact factor: 32.976

Review 3.  Diagnostic accuracy of SPECT, PET, and MRS for primary central nervous system lymphoma in HIV patients: A systematic review and meta-analysis.

Authors:  Mo Yang; James Sun; Harrison X Bai; Yongguang Tao; Xiangqi Tang; Lisa J States; Zishu Zhang; Jianhua Zhou; Michael D Farwell; Paul Zhang; Bo Xiao; Li Yang
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

4.  Restriction Fragment Length Polymorphism-based Genotyping of Toxoplasma gondii from Autopsy-Proven Cases of Acquired Immunodeficiency Syndrome-associated Cerebral Toxoplasmosis.

Authors:  B R Vijaykumar; R Sai Kant; C Rajendran; Swathi U Lekshmi; Sundar Keerthana; Anita Mahadevan; S K Shankar; R S Jayshree
Journal:  Ann Indian Acad Neurol       Date:  2018 Oct-Dec       Impact factor: 1.383

5.  A Novel Case of Solitary Cerebral Toxoplasmosis Mimicking Glioblastoma as the First Presentation of HIV.

Authors:  Moisés León Ruiz
Journal:  J Clin Neurol       Date:  2016-04       Impact factor: 3.077

6.  Application of stereotactic biopsy for diagnosing intracranial lesions in patients with AIDS in China: Report of 7 cases.

Authors:  Ji-Bo Zhang; Kai Fu; Rui Gong; Xue-Meng Liu; Li-Dao Chen; Yong-Xi Zhang; Gui-Fang Yang; Jie Zhang
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.